For FDA, the sixth authorization of the Prescription Drug User Fee Agreement (PDUFA VI) marks a positive shift in the relationship between the agency and industry.
PDUFA VI: 'Building Trust' Is Theme Of FDA-Industry Negotiations
Major achievements of latest drug user fee agreement include focus on drug development cycle, more review time and pilot programs, FDA and industry reps tell DIA meeting.
